Skip to main content
Top
Published in: Abdominal Radiology 6/2016

01-06-2016

Inherited renal carcinomas

Authors: Akira Kawashima, Scott W. Young, Naoki Takahashi, Bernard F. King, Thomas D. Atwell

Published in: Abdominal Radiology | Issue 6/2016

Login to get access

Abstract

Hereditary forms of kidney carcinoma account for 5–8% of all malignant kidney neoplasms. The renal tumors are often multiple and bilateral and occur at an earlier age. Each of the hereditary kidney carcinoma syndromes is associated with specific gene mutations as well as a specific histologic type of kidney carcinoma. The presence of associated extrarenal manifestations may suggest a hereditary kidney cancer syndrome. Radiology is most commonly used to screen and manage patients with hereditary kidney cancer syndromes. This manuscript reviews the clinical and imaging findings of well-defined inherited kidney cancer syndromes including von Hippel–Lindau disease, Birt–Hogg–Dubé syndrome, hereditary papillary renal carcinoma syndrome, hereditary leiomyomatosis and RCC syndrome, tuberous sclerosis complex, and Lynch syndrome.
Literature
2.
go back to reference Shuch B, Vourganti S, Ricketts CJ, et al. (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 32(5):431–437CrossRefPubMedPubMedCentral Shuch B, Vourganti S, Ricketts CJ, et al. (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 32(5):431–437CrossRefPubMedPubMedCentral
3.
4.
go back to reference Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 178(6):1499–1506CrossRefPubMed Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 178(6):1499–1506CrossRefPubMed
5.
go back to reference Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26(6):1795–1806; discussion 806-10 Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26(6):1795–1806; discussion 806-10
6.
go back to reference Vikram R, Sandler CM, Ng CS (2009) Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol. 192(6):1488–1493CrossRefPubMed Vikram R, Sandler CM, Ng CS (2009) Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol. 192(6):1488–1493CrossRefPubMed
7.
go back to reference Alshumrani G, O’Malley M, Ghai S, et al. (2010) Small (<or = 4 cm) cortical renal tumors: characterization with multidetector CT. Abdom Imaging. 35(4):488–493CrossRefPubMed Alshumrani G, O’Malley M, Ghai S, et al. (2010) Small (<or = 4 cm) cortical renal tumors: characterization with multidetector CT. Abdom Imaging. 35(4):488–493CrossRefPubMed
8.
go back to reference Sasiwimonphan K, Takahashi N, Leibovich BC, et al. (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 263(1):160–168CrossRefPubMed Sasiwimonphan K, Takahashi N, Leibovich BC, et al. (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 263(1):160–168CrossRefPubMed
9.
go back to reference Vargas HA, Chaim J, Lefkowitz RA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology. 264(3):779–788CrossRefPubMed Vargas HA, Chaim J, Lefkowitz RA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology. 264(3):779–788CrossRefPubMed
10.
go back to reference Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 265(2):468–477CrossRefPubMedPubMedCentral Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 265(2):468–477CrossRefPubMedPubMedCentral
11.
go back to reference Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 267(2):444–453CrossRefPubMed Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 267(2):444–453CrossRefPubMed
12.
go back to reference Wehrli NE, Kim MJ, Matza BW, et al. (2013) Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma. AJR Am J Roentgenol. 201(6):1260–1267CrossRefPubMed Wehrli NE, Kim MJ, Matza BW, et al. (2013) Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma. AJR Am J Roentgenol. 201(6):1260–1267CrossRefPubMed
13.
go back to reference Sasaguri K, Takahashi N, Gomez-Cardona D, et al. (2015) Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol. 205(5):999–1007CrossRefPubMed Sasaguri K, Takahashi N, Gomez-Cardona D, et al. (2015) Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol. 205(5):999–1007CrossRefPubMed
14.
go back to reference Hotker AM, Mazaheri Y, Wibmer A, et al. (2016) Use of DWI in the differentiation of renal cortical tumors. AJR Am J Roentgenol. 206(1):100–105CrossRefPubMed Hotker AM, Mazaheri Y, Wibmer A, et al. (2016) Use of DWI in the differentiation of renal cortical tumors. AJR Am J Roentgenol. 206(1):100–105CrossRefPubMed
15.
go back to reference Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003) Hereditary renal cancers. Radiology. 226(1):33–46CrossRefPubMed Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003) Hereditary renal cancers. Radiology. 226(1):33–46CrossRefPubMed
16.
go back to reference Choudhary S, Sudarshan S, Choyke PL, Prasad SR (2009) Renal cell carcinoma: recent advances in genetics and imaging. Semin Ultrasound CT MR. 30(4):315–325CrossRefPubMed Choudhary S, Sudarshan S, Choyke PL, Prasad SR (2009) Renal cell carcinoma: recent advances in genetics and imaging. Semin Ultrasound CT MR. 30(4):315–325CrossRefPubMed
17.
go back to reference Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V (2015) Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 204(5):1031–1041CrossRefPubMed Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V (2015) Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 204(5):1031–1041CrossRefPubMed
18.
go back to reference Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol. 170(6 Pt 1):2163–2172CrossRefPubMed Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol. 170(6 Pt 1):2163–2172CrossRefPubMed
19.
go back to reference Richard S, Gardie B, Couve S, Gad S (2013) Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 23(1):26–37CrossRefPubMed Richard S, Gardie B, Couve S, Gad S (2013) Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 23(1):26–37CrossRefPubMed
20.
go back to reference Lonser RR, Glenn GM, Walther M, et al. (2003) von Hippel-Lindau disease. Lancet. 361(9374):2059–2067CrossRefPubMed Lonser RR, Glenn GM, Walther M, et al. (2003) von Hippel-Lindau disease. Lancet. 361(9374):2059–2067CrossRefPubMed
21.
go back to reference Ho TH, Jonasch E (2014) Genetic kidney cancer syndromes. J Natl Compr Canc Netw. 12(9):1347–1355PubMed Ho TH, Jonasch E (2014) Genetic kidney cancer syndromes. J Natl Compr Canc Netw. 12(9):1347–1355PubMed
22.
go back to reference Mester JL, Zhou M, Prescott N, Eng C (2012) Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology 79(5):1187 e1–e7 Mester JL, Zhou M, Prescott N, Eng C (2012) Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology 79(5):1187 e1–e7
23.
go back to reference Verine J, Pluvinage A, Bousquet G, et al. (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 58(5):701–710CrossRefPubMed Verine J, Pluvinage A, Bousquet G, et al. (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 58(5):701–710CrossRefPubMed
25.
go back to reference Joly D, Mejean A, Correas JM, et al. (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol. 185(6):2056–2060CrossRefPubMed Joly D, Mejean A, Correas JM, et al. (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol. 185(6):2056–2060CrossRefPubMed
26.
go back to reference Park BK, Kim CK, Park SY, Shen SH (2013) Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol. 54(4):418–427CrossRefPubMed Park BK, Kim CK, Park SY, Shen SH (2013) Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol. 54(4):418–427CrossRefPubMed
27.
go back to reference Yang B, Autorino R, Remer EM, et al. (2013) Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up. Urol Oncol. 31(5):686–692CrossRefPubMed Yang B, Autorino R, Remer EM, et al. (2013) Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up. Urol Oncol. 31(5):686–692CrossRefPubMed
28.
go back to reference Menko FH, van Steensel MA, Giraud S, et al. (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 10(12):1199–1206CrossRefPubMed Menko FH, van Steensel MA, Giraud S, et al. (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 10(12):1199–1206CrossRefPubMed
29.
go back to reference Adeniran AJ, Shuch B, Humphrey PA (2015) Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 39(12):e1–e18CrossRefPubMed Adeniran AJ, Shuch B, Humphrey PA (2015) Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 39(12):e1–e18CrossRefPubMed
30.
go back to reference Pavlovich CP, Grubb RL 3rd, Hurley K, et al. (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol. 173(5):1482–1486CrossRefPubMed Pavlovich CP, Grubb RL 3rd, Hurley K, et al. (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol. 173(5):1482–1486CrossRefPubMed
31.
go back to reference Zbar B, Tory K, Merino M, et al. (1994) Hereditary papillary renal cell carcinoma. J Urol. 151(3):561–566PubMed Zbar B, Tory K, Merino M, et al. (1994) Hereditary papillary renal cell carcinoma. J Urol. 151(3):561–566PubMed
33.
go back to reference Chen YB, Brannon AR, Toubaji A, et al. (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 38(5):627–637CrossRefPubMedPubMedCentral Chen YB, Brannon AR, Toubaji A, et al. (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 38(5):627–637CrossRefPubMedPubMedCentral
34.
go back to reference Merino MJ, Torres-Cabala C, Pinto P, Linehan WM (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 31(10):1578–1585CrossRefPubMed Merino MJ, Torres-Cabala C, Pinto P, Linehan WM (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 31(10):1578–1585CrossRefPubMed
35.
go back to reference Grubb RL, 3rd, Franks ME, Toro J, et al. (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074–2079; discussion 9-80. Grubb RL, 3rd, Franks ME, Toro J, et al. (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074–2079; discussion 9-80.
36.
go back to reference Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med. 355(13):1345–1356CrossRefPubMed Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med. 355(13):1345–1356CrossRefPubMed
38.
go back to reference Jinzaki M, Tanimoto A, Narimatsu Y, et al. (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology. 205(2):497–502CrossRefPubMed Jinzaki M, Tanimoto A, Narimatsu Y, et al. (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology. 205(2):497–502CrossRefPubMed
39.
go back to reference Froemming AT, Boland J, Cheville J, Takahashi N, Kawashima A (2013) Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol. 200(2):W178–W186CrossRefPubMed Froemming AT, Boland J, Cheville J, Takahashi N, Kawashima A (2013) Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol. 200(2):W178–W186CrossRefPubMed
40.
go back to reference Tsukada J, Jinzaki M, Yao M, et al. (2013) Epithelioid angiomyolipoma of the kidney: radiological imaging. Int J Urol. 20(11):1105–1111CrossRefPubMed Tsukada J, Jinzaki M, Yao M, et al. (2013) Epithelioid angiomyolipoma of the kidney: radiological imaging. Int J Urol. 20(11):1105–1111CrossRefPubMed
41.
go back to reference Mork M, Hubosky SG, Roupret M, et al. (2015) Lynch syndrome: a primer for urologists and panel recommendations. J Urol. 194(1):21–29CrossRefPubMed Mork M, Hubosky SG, Roupret M, et al. (2015) Lynch syndrome: a primer for urologists and panel recommendations. J Urol. 194(1):21–29CrossRefPubMed
42.
go back to reference Goecke T, Schulmann K, Engel C, et al. (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 24(26):4285–4292CrossRefPubMed Goecke T, Schulmann K, Engel C, et al. (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 24(26):4285–4292CrossRefPubMed
43.
go back to reference Roupret M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 54(6):1226–1236CrossRefPubMed Roupret M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 54(6):1226–1236CrossRefPubMed
44.
go back to reference Crockett DG, Wagner DG, Holmang S, Johansson SL, Lynch HT (2011) Upper urinary tract carcinoma in Lynch syndrome cases. J Urol. 185(5):1627–1630CrossRefPubMed Crockett DG, Wagner DG, Holmang S, Johansson SL, Lynch HT (2011) Upper urinary tract carcinoma in Lynch syndrome cases. J Urol. 185(5):1627–1630CrossRefPubMed
45.
go back to reference Kawashima A, Vrtiska TJ, LeRoy AJ, et al. (2004) CT urography. Radiographics. 24(Suppl 1):S35–S54; discussion S5-8. Kawashima A, Vrtiska TJ, LeRoy AJ, et al. (2004) CT urography. Radiographics. 24(Suppl 1):S35–S54; discussion S5-8.
46.
go back to reference Hubosky SG, Boman BM, Charles S, Bibbo M, Bagley DH (2013) Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome). BJU Int. 112(6):813–819CrossRefPubMed Hubosky SG, Boman BM, Charles S, Bibbo M, Bagley DH (2013) Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome). BJU Int. 112(6):813–819CrossRefPubMed
Metadata
Title
Inherited renal carcinomas
Authors
Akira Kawashima
Scott W. Young
Naoki Takahashi
Bernard F. King
Thomas D. Atwell
Publication date
01-06-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0743-6

Other articles of this Issue 6/2016

Abdominal Radiology 6/2016 Go to the issue

Invited Article

Cystic renal masses

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.